Finland· FI-REL-REL7893
Imipramin
A imipramine product, registered in Finland by Alpharma ApS. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Imipramine is registered in 11 of 19 countries.
Countries holding a registration under ATC N06AA02 (imipramine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Imipramine · ATC N06AA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Manufacturer
- Alpharma ApS
- Country
- Finland (FI)
- ATC code
- N06AA02
- ATC class
- Imipramine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
475 interactions on record for imipramine.
Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Imipramine · interactions on record
475 records
- 64 severe
- 252 moderate
- 16 minor
- 60 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
83 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06AA02
Imipramine, as other registers publish it.
- DenmarkImipramin "DAK"Orifarm Healthcare A/S
- DenmarkImipramin "DAK"Orifarm Healthcare A/S
- GermanyImipramin NeuraxpharmNeuraxpharm Arzneimittel Gmbh
- NorwayImipramin-neuraxpharmNeuraxpharm Arzneimittel
- CanadaIMIPRAMINEAA PHARMA INC
- CanadaIMIPRAMINEAA PHARMA INC
- CanadaIMIPRAMINEAA PHARMA INC
- CanadaIMIPRAMINEAA PHARMA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/51b7717f-4ab5-4160-909a-303e20e8f5c3 GET /v1/drugs/51b7717f-4ab5-4160-909a-303e20e8f5c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.1",
"form": "tabletti",
"route": null,
"ddd_unit": "g",
"strength": "25 mg",
"atc_label": "imipramiini",
"ma_number": "4118",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL7893",
"authorised_at": "1966-09-28"
}See everything about imipramine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.